Summary
Bone morphogenetic proteins (BMPs) have multiple biologic functions, including bone formation and embryonic induction. One of these proteins, BMP-6, was reportedly expressed at high levels in human prostate cancers that had also metastasized to bone. This study investigated both BMP-6 mRNA and protein expression in normal and malignant rat and human prostate tissues. BMP-6 was detected in both rat normal prostate and in Dunning rat-prostate adenocarcinoma sublines. The levels of BMP-6 mRNA and protein were similar for normal and malignant rat prostate, regardless of the metastatic potential. Moreover, castration had no apparent effect on BMP-6 production in rat normal ventral prostate, suggesting an androgen-independent gene regulation of this protein. BMP-6 mRNA and protein were also produced by normal and neoplastic human prostate cancer (radical prostatectomy specimens and human carcinoma cell lines DU145 and PC3). BMP-6 mRNA and protein expression, however, was higher in prostate cancer as compared with adjacent normal prostate, with higher-grade tumors (Gleason score of 6 or more) having greater BMP-6 immunostaining than the lower-grade tumors (Gleason score of 4 or less). Taken together, these results suggest that BMP-6 protein expression may serve as a potential marker for prostate cancer but not as a metastatic marker. Moreover, BMP-6 may contribute to prostate neoplastic behavior even in the absence of androgens.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bentley H, Hamdy FC, Hart KA, Seid JM, Williams JL, Johnstone D, Russell RGG (1992) Expression of bone morphogenetic proteins in human prostatic adenocarcinoma and benign prostatic hyperplasia. Br J Cancer 66:1159–1163
Celeste AJ, Iannazzi JA, Taylor RC, Hewick RM, Rosen V, Wang EA, Wozney JM (1990) Identification of transforming growth factor beta family members present in bone-inductive protein purified from bovine bone. Proc Natl Acad Sci USA 87:9843–9847
Derynck R, Goeddel DV, Ullrich A, Gutterman JU, Williams RD, Bringman TS (1987) Synthesis of messenger RNAs for transforming growth factors alpha and beta and the epidermal growth factor receptor by human tumors. Cancer Res 47:707–712
Harris SE, Harris MA, Mahy P, Wozney J, Feng JQ, Mundy GR (1994) Expression of bone morphogenetic protein messenger RNAs by normal rat and human prostate and prostate cancer cells. Prostate 24:204–211
Isaacs JT (1987) Development and characteristics of the animal model systems for the study of prostatic cancer. In: Coffey D, Bruchovsky N, Gardner W, et al. (eds) Current concepts and approaches to the study of prostatic cancer. Alan R Liss, New York, pp 513–576
Isaacs JT, Yu GW, Coffey DS (1981) The characterization of a newly identified, highly metastatic variety of Dunning R3327 rat prostatic adenocarcinoma system: the MAT LyLu tumor. Invest Urol 19:20–23
Kyprianou N, Isaacs JT (1989) Expression of transforming growth factor-beta in the rat ventral prostate during castration-induced programmed cell death. Mol Endocrinol 3:1515–1522
Loveridge N, Farquharson C, Hesketh JE, Jakowlew SB, Whitehead CC, Thorp BH (1993) The control of chondrocyte differentiation during endochondral bone growth in vivo: changes in TGF-β and the proto-oncogene c-myc. J Cell Sci 105:949–956
Lyons K, Graycar JL, Lee A, Hashmi S, Lindquist PB, Chen EY, Hogan BLM, Derynck R (1989) Vgr-1, a mammalian gene related to xenopus Vg-1, is a member of the transforming growth factor beta gene superfamily. Proc Natl Acad Sci USA 86:4554–4558
Lyons KM, Jones CM, Hogan BLM (1991) The DVR gene family in embryonic development. Trends Genet 7:408–412
Matuo Y, Nishi N, Takasuka H, Masuda Y, Nishikawa K, Isaacs JT, Adams PS, McKeehan WL, Sato GH (1990) Production and significance of TGF-beta in AT-3 metastatic cell line established from the Dunning rat prostatic adenocarcinoma. Biochem Biophys Res Commun 166:840–847
Noda M, Camilliere JJ (1989) In vivo stimulation of bone formation by transforming growth factor-beta. Endocrinology 124:2991–2994
Ozkaynak E, Rueger DC, Drier EA, Corbett C, Ridge RJ, Sampath TK, Oppermann H (1990) OP-1 cDNA encodes an osteogenic protein in the TGF-beta family. EMBO J 9:2085–2093
Sampath TK, Reddi AH (1981) Dissociative extraction and reconstitution of extracellular matrix components involved in local bone differentiation. Proc Natl Acad Sci USA 78:7599–7603
Steiner MS (1993) The role of peptide growth factors in the prostate: a review. Urology 42:99–110
Steiner MS, Barrack ER (1992) Transforming growth factor-β1 overproduction in prostate cancer: effects on growth in vivo and in vitro. Mol Endocrinol 6:15–25
Steiner MS, Zhou Z, Tonb DC, Barrack ER (1994) Expression of transforming growth factor-β1 in prostate cancer. Endocrinology 135:2240–2247
Wall NA, Blessing M, Wright CVE, Hogan BLM (1993) Biosynthesis and in vivo localization of the decapentaplegic-Vg-related protein, DVR-6 (bone morphogenetic protein-6). J Cell Biol 120:493–502
Wilding G, Zugmeier G, Knabbe C, Flanders KC, Gelmann E (1989) Differential effects of transforming growth factor beta on human prostate cancer cells in vitro. Mol Cell Endocrinol 62:79–87
Wozney JM (1992) The bone morphogenetic protein family and osteogenesis. Mol Reprod Dev 32:160–167
Wozney JM, Rosen V, Celeste AJ, Mitsock LM, Whitters MJ, Kriz RW, Hewick RM, Wang EA (1988) Novel regulators of bone formation: molecular clones and activities. Science 242:1528–1534
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Barnes, J., Anthony, C.T., Wall, N. et al. Bone morphogenetic protein-6 expression in normal and malignant prostate. World J Urol 13, 337–343 (1995). https://doi.org/10.1007/BF00191214
Issue Date:
DOI: https://doi.org/10.1007/BF00191214